Viewing Study NCT05263869


Ignite Creation Date: 2025-12-24 @ 10:53 PM
Ignite Modification Date: 2025-12-25 @ 8:22 PM
Study NCT ID: NCT05263869
Status: UNKNOWN
Last Update Posted: 2022-12-02
First Post: 2022-02-21
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study of MRG002 in Treatment of Advanced HER-2 Positive Breast Cancer Patients
Sponsor: Shanghai Miracogen Inc.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module